Minireviews
Copyright ©2016 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Nephrol. Mar 6, 2016; 5(2): 158-165
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.158
Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management
Julia V Fiuk, Brad F Schwartz
Julia V Fiuk, Brad F Schwartz, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL 62794, United States
Author contributions: Both the authors contributed equally to the conceptualization, research, writing and editing of this manuscript.
Conflict-of-interest statement: Neither author (Julia V Fiuk or Brad F Schwartz) have any conflicts of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Julia V Fiuk, MD, Division of Urology, Southern Illinois University School of Medicine, 301 N 8th St, 4th Floor, PO Box 19665, Springfield, IL 62794, United States. jfiuk@siumed.edu
Telephone: +1-217-5457217 Fax: +1-217-5457305
Received: June 12, 2015
Peer-review started: June 15, 2015
First decision: July 10, 2015
Revised: November 11, 2015
Accepted: January 27, 2016
Article in press: January 29, 2016
Published online: March 6, 2016
Processing time: 263 Days and 9 Hours
Core Tip

Core tip: In the appropriate patient population, minimally invasive endoscopic treatment of upper tract urothelial carcinoma provides comparable oncologic and survival outcomes to the gold standard radical nephroureterectomy.